Functional assessment of joint use in experimental inflammatory murine arthritis
- PMID: 8483030
- DOI: 10.1002/jor.1100110204
Functional assessment of joint use in experimental inflammatory murine arthritis
Abstract
A select group of cartilage proteoglycans (fetal human, porcine, and canine articular cartilages and human osteophytes, all depleted of chondroitin sulfate) produces progressive polyarthritis and spondylitis in BALB/c mice. The development of the disease in this murine strain is dependent on the expression of both cell-mediated and humoral immunities to host mouse cartilage proteoglycan. Autoantibodies have been detected in sera of arthritis animals from the fifth to sixth week after immunization, and their appearance precedes the development of the first clinical symptoms by a few days in animals with passively transferred arthritis. In this preliminary experiment, we describe several functional tests and gait analyses in normal mice, in acutely and chronically arthritic mice, and in randomly selected mice with proteoglycan-induced and collagen-induced arthritis. The procedures revealed that changes in joint use and gait could predate by weeks the appearance of the first clinical symptoms (joint swelling, redness, and joint stiffness) of arthritis in mice. Moreover, abnormalities measured by functional tests, such as strength of grip and maintenance of posture on sandpaper, wood, or vinyl surfaces at three different tilt angles (30, 45, and 60 degrees), and gait analysis preceded the appearance of autoantibodies in sera of immunized animals; this indicates that such measurements could provide a noninvasive and simple method to assess joint function accurately during the development of arthritis.
Similar articles
-
Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.Arthritis Rheum. 1998 Jun;41(6):1007-18. doi: 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6. Arthritis Rheum. 1998. PMID: 9627010
-
Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease.Arthritis Rheum. 2001 Mar;44(3):682-92. doi: 10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E. Arthritis Rheum. 2001. PMID: 11263784
-
Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation.J Immunol. 1998 Apr 15;160(8):3812-9. J Immunol. 1998. PMID: 9558085
-
Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.J Rheumatol. 1995 Dec;22(12):2250-8. J Rheumatol. 1995. PMID: 8835558
-
Immunity to cartilage proteoglycans.J Rheumatol Suppl. 1992 Apr;33:36-9. J Rheumatol Suppl. 1992. PMID: 1593599 Review.
Cited by
-
Aggrecan: A Target Molecule of Autoimmune Reactions.Pathol Oncol Res. 1996;2(4):219-228. doi: 10.1007/BF02904814. Pathol Oncol Res. 1996. PMID: 11173607
-
Aging Phenotypes of Common Marmosets (Callithrix jacchus).J Aging Res. 2012;2012:567143. doi: 10.1155/2012/567143. Epub 2012 Mar 4. J Aging Res. 2012. PMID: 22506113 Free PMC article.
-
Effect of pregnancy on proteoglycan-induced progressive polyarthritis in BALB/c mice: remission of disease activity.Clin Exp Immunol. 1993 Nov;94(2):252-60. doi: 10.1111/j.1365-2249.1993.tb03440.x. Clin Exp Immunol. 1993. PMID: 8222315 Free PMC article.
-
Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathy.ACS Chem Neurosci. 2023 Jan 18;14(2):235-245. doi: 10.1021/acschemneuro.2c00539. Epub 2022 Dec 26. ACS Chem Neurosci. 2023. PMID: 36571847 Free PMC article.
-
Modeling Complex Orthopedic Trauma in Rodents: Bone, Muscle and Nerve Injury and Healing.Front Pharmacol. 2021 Feb 1;11:620485. doi: 10.3389/fphar.2020.620485. eCollection 2020. Front Pharmacol. 2021. PMID: 33597884 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases